Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation libraryCHEMIF19.62023-02-0118OAAI
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing PropertiesPHARMACEUTICSIF5.52023-01-225OAAI
A NOVEL IL12-BASED IMMUNOCYTOKINE TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) FOR THE TREATMENT OF CANCERJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-071OA
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid TumorsCLINICAL CANCER RESEARCHIF10.22022-10-109OA
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody基于新型抗人FAP单克隆抗体的IL-12融合蛋白的制备和体内验证JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-09-1415OAAI
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applicationsPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12021-04-1376OA
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivoMABSIF7.32020-11-0213OAAI